GAMBALE, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 368
EU - Europa 321
AS - Asia 166
OC - Oceania 7
AF - Africa 3
SA - Sud America 2
Totale 867
Nazione #
US - Stati Uniti d'America 365
RU - Federazione Russa 176
HK - Hong Kong 73
IT - Italia 56
SG - Singapore 47
IE - Irlanda 44
CN - Cina 17
SE - Svezia 17
ID - Indonesia 12
JO - Giordania 10
AT - Austria 8
AU - Australia 7
FI - Finlandia 5
DE - Germania 4
CA - Canada 3
CH - Svizzera 3
GB - Regno Unito 3
IN - India 3
AE - Emirati Arabi Uniti 2
BR - Brasile 2
CI - Costa d'Avorio 2
BE - Belgio 1
IQ - Iraq 1
KE - Kenya 1
LT - Lituania 1
LV - Lettonia 1
NL - Olanda 1
TH - Thailandia 1
UA - Ucraina 1
Totale 867
Città #
Santa Clara 245
Hong Kong 66
Dublin 44
Singapore 31
Florence 20
Jakarta 12
Ashburn 10
Chandler 10
Vienna 8
Los Angeles 7
Melbourne 7
Boardman 5
Shanghai 5
Recanati 4
Bern 3
Bremen 3
Helsinki 3
Moscow 3
Pune 3
Abidjan 2
Altamura 2
Boston 2
Lappeenranta 2
Lawrence 2
Milan 2
Princeton 2
Salzano 2
Toronto 2
Verona 2
Yubileyny 2
Ann Arbor 1
Basra 1
Bologna 1
Brasília 1
Brussels 1
Buffalo 1
Cambridge 1
Campi Bisenzio 1
Fairfield 1
Hillsboro 1
Nairobi 1
Newark 1
Nuremberg 1
Ottawa 1
Riga 1
San Diego 1
Seattle 1
Stockholm 1
Sulzano 1
São Paulo 1
The Dalles 1
Trumbull 1
Wilmington 1
Totale 534
Nome #
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 106
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 84
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 83
Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice 81
Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity 80
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 78
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 76
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25) 68
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study 67
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on Survival 66
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma 61
Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients 22
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies 13
Head and neck melanoma: the eyelid region has a better prognosis and easier management: a retrospective survey and systematic review 10
Totale 895
Categoria #
all - tutte 3.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.893


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202213 0 0 0 0 0 0 0 5 0 2 2 4
2022/2023135 4 7 3 18 2 30 23 20 18 0 5 5
2023/202491 2 7 10 8 9 15 2 16 2 3 5 12
2024/2025656 21 64 45 110 183 134 16 50 33 0 0 0
Totale 895